Clinical and Economic Outcomes of New Oral Anticoagulants in Orthopaedics Cover

.blurhash-client-img { display: none !important; }

Clinical and Economic Outcomes of New Oral Anticoagulants in Orthopaedics

EABR. Experimental and Applied Biomedical Research

Volume 19 (2018): Issue 1 (March 2018)

By: Dragana Lakic, Jovana Travica, Marina Odalovic and Ivana Tadic

Open Access

|Apr 2018

Authors

Dragana Lakic

dlakic@pharmacy.bg.ac.rs

Department for Social Pharmacy and Pharmacy Legislation, University of Belgrade – Faculty of Pharmacy, Serbia

Jovana Travica

Department for Social Pharmacy and Pharmacy Legislation, University of Belgrade – Faculty of Pharmacy, Serbia

Marina Odalovic

Department for Social Pharmacy and Pharmacy Legislation, University of Belgrade – Faculty of Pharmacy, Serbia

Ivana Tadic

Department for Social Pharmacy and Pharmacy Legislation, University of Belgrade – Faculty of Pharmacy, Serbia

DOI: https://doi.org/10.1515/sjecr-2017-0066 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454

Journal RSS Feed

Language: English

Page range: 3 - 9

Submitted on: Jul 29, 2016

Accepted on: Aug 9, 2016

Published on: Apr 11, 2018

Published by: University of Kragujevac, Faculty of Medical Sciences

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

new oral anticoagulant,

orthopaedic surgery,

clinical outcomes,

economic outcomes

Related subjects:

Clinical medicine,

Clinical medicine, other

© 2018 Dragana Lakic, Jovana Travica, Marina Odalovic, Ivana Tadic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 19 (2018): Issue 1 (March 2018)Next article